Key result
High-sensitivity troponin I was significantly associated with myocardial infarction in patients aged ≥75 years (AUROC 0.751; 95% CI 0.580-0.922; P=0.003), with an optimal cut-off of 141 ng/L.
Why the study?
Older patients evaluated in the ED for suspected MI frequently show unspecific hs-TnI elevations, making interpretation challenging. This study aimed to identify the interaction of multimorbidity and frailty with hs-TnI levels in this population.
How do frailty and multimorbidity affect the interpretation of high-sensitivity troponin I levels for diagnosing myocardial infarction in patients aged ≥75?
Cohort (n=268)
No
How do frailty and multimorbidity affect the interpretation of high-sensitivity troponin I levels for diagnosing myocardial infarction in patients aged ≥75?
Effect estimate: AUROC 0.751 (95% CI 0.580-0.922)
p-value: p=0.003
In geriatric patients with suspected MI, frailty and cardiovascular multimorbidity significantly influence hs-TnI levels, suggesting a higher optimal cut-off (141 ng/L) may be needed for accurate diagnosis.
Frailty and multimorbidity may confound hs-TnI interpretation in older adults; leaves open frailty-adjusted thresholds for prospective validation.
BACKGROUND: Older patients evaluated in Emergency Departments (ED) for suspect Myocardial Infarction (MI) frequently exhibit unspecific elevations of serum high-sensitivity troponin I (hs-TnI), making interpretation particularly challenging for emergency physicians. The aim of this longitudinal study was to identify the interaction of multimorbidity and frailty with hs-TnI levels in older patients seeking emergency care. METHODS: A group of patients aged≥75 with suspected MI was enrolled in our acute geriatric ward immediately after ED visit. Multimorbidity and frailty were measured with Cumulative Illness Rating Scale (CIRS) and Clinical Frailty Scale (CFS), respectively. The association of hs-TnI with MI (main endpoint) was assessed by calculation of the Area Under the Receiver-Operating Characteristic Curve (AUROC), deriving population-specific cut-offs with Youden test. The factors associated with hs-TnI categories, including MI, CFS and CIRS, were determined with stepwise multinomial logistic regression. The association of hs-TnI with 3-month mortality (secondary endpoint) was also investigated with stepwise logistic regression. RESULTS: Among 268 participants (147 F, median age 85, IQR 80-89), hs-TnI elevation was found in 191 cases (71%, median 23 ng/L, IQR 11-65), but MI was present in only 12 cases (4.5%). hs-TnI was significantly associated with MI (AUROC 0.751, 95% CI 0.580-0.922, p = 0.003), with an optimal cut-off of 141 ng/L. hs-TnI levels ≥141 ng/L were significantly associated with CFS (OR 1.58, 95% CI 1.15-2.18, p = 0.005), while levels <141 ng/L were associated with the cardiac subscore of CIRS (OR 1.36, 95% CI 1.07-1.71, p = 0.011). CFS, but not hs-TnI levels, predicted 3-month mortality. CONCLUSIONS: In geriatric patients with suspected MI, frailty and cardiovascular multimorbidity should be carefully considered when interpreting emergency hs-TnI testing.
No takes yet. Share an insight, caveat, or question.
Ticinesi et al. (2021) conducted a cohort in Suspected Myocardial Infarction (n=268). High-sensitivity troponin I (hs-TnI) was evaluated on Myocardial Infarction (MI) (AUROC 0.751, 95% CI 0.580-0.922, p=0.003). High-sensitivity troponin I was significantly associated with myocardial infarction in patients aged ≥75 years (AUROC 0.751; 95% CI 0.580-0.922; P=0.003), with an optimal cut-off of 141 ng/L.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: